INO Positive Sentiment
INOVIO to Participate in December Investor Conferences
Tuesday, November 18, 2025 BiopharmaWatch Research 1 min read Key Takeaway: INOVIO Pharmaceuticals, a biotech firm specializing in DNA medicines, announced its participation in two upcoming investor conferences in December. The events include the Piper Sandler 37th Annual Healthcare Conference and the Oppenheimer Movers in Rare Disease Summit. Management will also hold one-on-one meetings with investors to discuss potential catalysts.
Full Press Release Details
PLYMOUTH MEETING, Pa.,Nov. 18, 2025/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:
Piper Sandler 37th Annual Healthcare Conference (New York, NY)Date:Tuesday, December 2Time:8:30-8:55 AM ETFormat:Fireside ChatWebcast:https://bit.ly/44af19l(live webcast and replay available for 90 days after the event)
Oppenheimer Movers in Rare Disease Summit (New York, NY)Date:Thursday, December 11Time:12:05-12:25 PM ETFormat:Panel -Elevator Pitches from Rare Disease Companies with Key Near-Term, Potentially Stock-Moving Catalysts
Members of INOVIO's management team will also be conducting one-on-one meetings with investors during these conferences.
About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visitwww.inovio.com.
ContactsMedia: Jennie Willson, (267) 429-8567,[email protected]Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505,[email protected]